Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2059947

CCCCC(N)(CCCC)Cc1ccccc1.Cl

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 1/20 0.50
S1PR1 known ✓ P21453 2/20 0.40
MAOB known ✓ P27338 1/20 0.38
SIGMAR1 known ✓ Q99720 1/20 0.38
S1PR4 known ✓ O95977 1/20 0.38
S1PR3 known ✓ Q99500 1/20 0.38
S1PR5 known ✓ Q9H228 1/20 0.38
TAAR1 Q96RJ0 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.41
HIF1A Q16665 1/20 0.41
CSNK1E P49674 1/20 0.39
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
TP53 P04637 1/20 0.38
TNNC1 P63316 4/20 0.38
SGPL1 O95470 1/20 0.38
GPR183 P32249 1/20 0.38
CERS2 Q96G23 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517037 0.98 SLC6A2 (0.52) SLC6A2TAAR1SMN1; SMN2HIF1AS1PR1
Hydrochloric Acid SCHEMBL11273751 0.93 SLC6A2 (0.47) SLC6A2TAAR1SMN1; SMN2S1PR1CSNK1E
Hydrochloric Acid SCHEMBL16427991 0.93 SLC6A2 (0.47) SLC6A2TAAR1SMN1; SMN2S1PR1CSNK1E
Methylamine SCHEMBL27796046 0.92 SLC6A2 (0.50) SLC6A2TAAR1SMN1; SMN2HIF1AS1PR1
SCHEMBL19253988 0.91 SLC6A2 (0.48) SLC6A2TAAR1SMN1; SMN2S1PR1CSNK1E
SCHEMBL6056161 0.91 SLC6A2 (0.48) SLC6A2TAAR1SMN1; SMN2S1PR1CSNK1E
SCHEMBL29107063 0.91 SLC6A2 (0.48) SLC6A2TAAR1SMN1; SMN2S1PR1CSNK1E
Hydrochloric Acid SCHEMBL6850888 0.89 SLC6A2 (0.47) SLC6A2TAAR1SMN1; SMN2S1PR1CSNK1E
SCHEMBL27893438 0.89 SLC6A2 (0.50) SLC6A2TAAR1SMN1; SMN2HIF1AS1PR1
Hydrochloric Acid SCHEMBL17710430 0.88 SLC6A2 (0.54) SLC6A2TAAR1SMN1; SMN2HIF1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019141-B1 HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANOPARTICLES, KIT OF PARTS AND USE THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2022-08-31 EP disclosed
EP-3426222-B1 PREFORMED DENTAL COMPOSITE CROWN, PROCESS OF PRODUCTION AND USE THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2020-04-29 EP disclosed
US-9782329-B2 Hardenable dental composition containing a mixture of agglomerated and aggregated nano-particles, kit of parts and use thereof SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2017-10-10 US disclosed
US-20160136059-A1 HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2016-05-19 US disclosed
EP-3019141-A1 HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF 3M Innovative Properties Company (US) 2016-05-18 EP disclosed
WO-2015006087-A1 HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-01-15 WO disclosed
US-8329776-B2 Dental composition containing a polyfunctional (meth)acrylate comprising urethane, urea or amide groups, method of production and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-12-11 US disclosed
US-20110053116-A1 DENTAL COMPOSITION CONTAINING A POLYFUNCTIONAL (METH)ACRYLATE COMPRISING URETHANE, UREA OR AMIDE GROUPS, METHOD OF PRODUCTION AND USE THEREOF SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2011-03-03 US disclosed
EP-2167013-B1 DENTAL COMPOSITION CONTAINING A POLYFUNCTIONAL (METH)ACRYLATE COMPRISING URETHANE, UREA OR AMIDE GROUPS, METHOD OF PRODUCTION AND USE THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2010-12-22 EP disclosed
EP-2008636-A1 Dental composition containing a polyfunctional (meth)acrylate comprising urethane, urea or amide groups, method of production and use thereof 3M Innovative Properties Company (US) 2008-12-31 EP disclosed
US-4067853-A ABRASION RESISTANT ACRYLIC POLYMERS FOR DENTURES ESPE FABRIK PHARMAZEUTISCHER PRAPARATE GMBH (DT) 1978-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053116-A1 DENTAL COMPOSITION CONTAINING A POLYFUNCTIONAL (METH)ACRYLATE COMPRISING URETHANE, UREA OR AMIDE GROUPS, METHOD OF PRODUCTION AND USE THEREOF MUS81, MAT1A, SMCHD1 SLC6A2 4536/4885S1PR1 4378/4885MAOB 1486/4885
US-20160136059-A1 HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF NOX3, ILK, NOX1 SLC6A2 4558/4885S1PR1 4879/4885MAOB 2255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.